TB remains the leading infectious killer of our time, responsible for 1.6 million deaths worldwide in 2017, with drug-resistant forms of TB threatening control efforts in many parts of the world.

UCSF discovery that may lead to new treatments for people with IPF.

UCSF scientists have figured out why some lung cancers become drug-resistant after initially responding to targeted therapies.

UC San Francisco, National Jewish Health and Centro de Neumología Pediátrica in Puerto Rico have been awarded nearly $10 million to address the root causes of asthma in children in Puerto Rico.

To develop novel therapies to treat specific subtypes of COPD, and potentially even to reverse some of the symptoms, scientists at UCSF are taking a precision medicine approach to the disease.

Claims by the tobacco industry that heated tobacco products (HTPs) are safer than conventional cigarettes are not supported by the industry’s own data and are likely to be misunderstood by consumers.

A group of researchers from the Gladstone Institutes, UCSF, and UC Berkeley used a systematic approach to get an entirely new look at the way tuberculosis infects people.

UCSF ranked sixth on the national Best Hospitals Honor Roll and received special recognition for exceptional performance in 15 medical specialties, including top-10 status in a dozen.